Frequently Asked Questions

Get answers to common questions about Semaglutide Program.

The program begins with a medical consult, baseline labs, and an individualized semaglutide plan. Dosing is titrated gradually, with telehealth follow-ups, lab reviews, and lifestyle coaching to safely optimize metabolism and weight over time.

Ideal candidates are adults with overweight or obesity seeking medically supervised weight loss, especially those with metabolic risk factors. We screen for contraindications like pregnancy, pancreatitis, or personal medication conflicts before enrollment.

We order baseline and periodic labs—metabolic panel, A1c, lipids, liver and kidney function, and pregnancy testing when applicable. Clinicians review results monthly to adjust dosage and ensure safety throughout treatment.

Appetite suppression often appears within weeks, with measurable weight changes around eight to twelve weeks for many clients. Results vary; consistent adherence and medical adjustments drive meaningful long-term progress and ongoing lifestyle support enhances outcomes.

Common side effects include nausea, mild gastrointestinal upset, and occasional dizziness, usually improving with dose adjustments. Rare but serious risks—like pancreatitis or gallbladder issues—are monitored; report severe symptoms immediately so clinicians can evaluate and modify treatment.

Yes. The program complements nutrition, exercise, and behavioral counseling. Combining other medications or supplements requires clinician approval to avoid interactions. We coordinate care with your providers to safely integrate semaglutide into a comprehensive weight-management strategy.